Insmed Inc. First Quarter Earnings Sneak Peek

Insmed Inc. (NASDAQ:INSM) will unveil its latest earnings on Tuesday, May 8, 2012. Insmed is a biopharmaceutical company focused on the development and commercialization of drugs to treat metabolic diseases and endocrine disorders within niche markets that have unmet medical needs. .

Insmed Inc. Earnings Preview Cheat Sheet

Wall St. Earnings Expectations: The average estimate of analysts is for net loss of 34 cents per share, a narrower loss from the year-earlier quarter net loss of 37 cents. During the past three months, the average estimate has moved up from a loss of 38 cents. Between one and three months ago, the average estimate moved up. It has been unchanged at a loss of 34 cents during the last month.

Past Earnings Performance: Last quarter, the company topped expectations by 10 cents, coming in at a loss of 28 cents per share versus a mean estimate of net loss of 38 cents per share. This followed two straight quarters of missing estimates.

Investing Insights: What’s the Future of Microsoft’s Stock?

A Look Back: In the fourth quarter of the last fiscal year, the company’s loss widened to a loss of a $8.2 million (29 cents a share) from a loss of $5.8 million (49 cents) a year earlier, but beat analyst expectations. Revenue rose 6.2% to $1.4 million from $1.3 million.

Key Stats:

On the top line, the company is looking to build on last quarter’s revenue increase, which snapped a string of revenue drops. Revenue fell 17% in the first quarter of the last fiscal year, 47.5% in the second quarter of the last fiscal year and 75.9% in the third quarter of the last fiscal year before climbing in the fourth quarter of the last fiscal year.

Stock Price Performance: Between February 6, 2012 and May 2, 2012, the stock price fell $2.53 (-48.1%), from $5.26 to $2.73. The stock price saw one of its best stretches over the last year between May 16, 2011 and May 31, 2011, when shares rose for 11 straight days, increasing 32.8% (+$2.65) over that span. It saw one of its worst periods between November 16, 2011 and November 25, 2011 when shares fell for seven straight days, dropping 12.3% (-37 cents) over that span.

(Company fundamentals by Xignite Financials. Earnings estimates provided by Zacks)

Don’t Miss These Additional Hot Stories:

Why Are These Health Stocks Feeling Under the Weather?

What Do Americans Think About Gold?>>

Here’s How to Bet on a Baby Boom>>